Browse by Person

2003

Giles, G.I. and Giles, N.M. and Collins, C.A. and Holt, K. and Fry, F.H. and Lowden, Philip and Gutowski, N.J. and Jacob, C. (2003) Electrochemical, in vitro and cell culture analysis of integrated redox catalysts: implications for cancer therapy. Chemical Communications 16 , pp. 2030-2031. ISSN 1359-7345.

Smith D.L. and Woodman B. and Mahal A. and Sathasivam K. and Ghazi-Noori S. and Lowden, Philip and Bates G.P. and Hockly E. (2003) Minocycline and doxycycline are not beneficial in a model of Huntington's disease. Annals of Neurology 54 (2), pp. 186-196. ISSN 0364-5134.

Hockly, E. and Richon, V.M. and Woodman, B. and Smith, D.L. and Zhou, X.B. and Rosa, E. and Sathasivam, K. and Ghazi-Noori, S. and Mahal, A. and Lowden, Philip and Steffan, J.S. and Marsh, J.L. and Thompson, L.M. and Lewis, C.M. and Marks, P.A. and Bates, G.P. (2003) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proceedings of the National Academy of Sciences of the United States of America 100 (4), pp. 2041-2046. ISSN 0027-8424.

2004

Lowden, Philip and Böhm, G.A. and Metcalfe, S. and Staunton, J. and Leadlay, P.F. (2004) New rapamycin derivatives by precursor-directed biosynthesis. ChemBioChem 5 (4), pp. 535-538. ISSN 1439-4227.

Corre, C. and Lowden, Philip (2004) The first biosynthetic studies of the azinomycins: acetate incorporation into azinomycin B. Chemical Communications 8 , 990 -991. ISSN 1359-7345.